Clicky

Health

Net Medical Adds Mobile on-site CLIA Labs in Response to Growth in Number of People Testing Positive for COVID

624 108 admin

ALBUQUERQUE, NM / ACCESSWIRE / June 14, 2022 / Net Medical (OTC Pink:NMXS) said today it is upgrading and increasing its fleet of mobile testing labs in response to previously reported growth in positive tests for…

Moderna Announces Omicron-Containing Bivalent Booster Candidate mRNA-1273.214 Demonstrates Superior Antibody Response Against Omicron

1200 277 Rick

Data Show Significantly Higher Geometric Mean Titer Ratios, Meeting Prespecified Endpoints for Superiority Against Omicron Variant mRNA-1273.214 Exhibited an 8-Fold Boost in Neutralizing Geometric Mean Titers Against Omicron Among Baseline Seronegative Participants Safety and Tolerability…

Moderna to Present at Upcoming Conferences in June 2022

1200 277 Lauren

CAMBRIDGE, MA / ACCESSWIRE / June 1, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced its participation in the following upcoming investor conferences: 2022 Jefferies Healthcare Conference…

Moderna to Present at the UBS 2022 Global Healthcare Conference

1200 277 Jessi

CAMBRIDGE, MA / ACCESSWIRE / May 18, 2022 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced its participation in a fireside chat at the UBS 2022 Global Healthcare…

EIDL Economic Injury Disaster Loans SBA COVID Deadline May 6th

2048 441 Jessi

NEW YORK, NY / ACCESSWIRE / April 30, 2022 / The U.S. Small Business Administration (SBA) laid down a final ultimatum on the Economic Injury Disaster Loan (EIDL) program. On Thursday the SBA announced more urgent…

V. James DeSimone Law Files Landmark COVID Related Wrongful Death Suit – Lawyer News

500 500 Jessi

MARINA DEL REY, CA / ACCESSWIRE / April 22, 2022 / A landmark lawsuit filed in California over a man’s death from COVID-19 places the onus directly on an employer for refusing to make reasonable workplace accommodations for…

IAVI and Moderna Partner to Tackle Broad Global Health Priorities Using mRNA for Vaccines and Antibodies

1200 277 Rick

Collaboration to target bacterial and viral pathogens including HIV, SARS-CoV-2, antimicrobial-resistant pathogens, and tuberculosis NEW YORK, NY and CAMBRIDGE, MA / ACCESSWIRE / April 7, 2022 / Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA…

Moderna Receives FDA Approval for Emergency Use Authorization of 2nd Booster Dose of Its COVID-19 Vaccine, mRNA-1273

1200 277 Jessi

CAMBRIDGE, MA / ACCESSWIRE / March 29, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced today that it has received approval from the U.S. Food and Drug…

Baebies Earns CE Mark for FINDER SARS-CoV-2 Point-of-Care Testing Platform

901 451 Riley

DURHAM, NC / ACCESSWIRE / March 24, 2022 / Baebies® announced today it has received CE Mark for its FINDER® SARS-CoV-2 point-of-care test, which performs RT-PCR testing to detect SARS-CoV-2 on the FINDER 1.5 Instrument.…

Moderna Submits Amendment to the Emergency Use Authorization for an Additional Booster Dose of its COVID-19 Vaccine in the U.S.

1200 277 Riley

CAMBRIDGE, MA / ACCESSWIRE / March 17, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has submitted a request to the U.S. Food and…